BioWorld MedTech

Sep. 11, 2015

Funding Breast Imaging Technology: Delphinus raises $39.5M to fuel SoftVue commercialization efforts

A company developing an imaging system for breast cancer screening is getting noticed in the venture capital community. Delphinus Medical Technologies (Plymouth Township, Mich.) has raised $39.5 million in a Series C financing round. Read More

Inside the Beltway: MedPAC backs Linac utilization rate of 70% seen in MPFS draft

Epic going Dutch: Epic Systems goes global with the launch of Dutch electronic medical records

Second Feasibility study Underway: Lumicell receives FDA nod for GI cancer imaging feasibility study

Agreements/contracts: IBM opens Watson Health center with new partners

Buyout on the Mind: Mindray lowers privatization bid to $3.2 billion citing weak financials

Patents: VolitionRx receives patent for epigenetic blood test

HIT Bits: AccentHealth launches digital patient engagement platform

Briefly noted

People in Places

Products

MDD's Diagnostics Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 24, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 24, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.